Progress and prospects toward our understanding of the evolution of dosage compensation by Vicoso, Beatriz & Bachtrog, Doris
Progress and prospects toward our understanding
of the evolution of dosage compensation
Beatriz Vicoso & Doris Bachtrog
Published online: 23 July 2009
# The Author(s) 2009. This article is published with open access at Springerlink.com
Abstract In many eukaryotic organisms, gender is
determined by a pair of heteromorphic sex chromo-
somes. Degeneration of the non-recombining Y
chromosome is a general facet of sex chromosome
evolution. Selective pressure to restore expression
levels of X-linked genes relative to autosomes
accompanies Y-chromosome degeneration, thus driv-
ing the evolution of dosage compensation mecha-
nisms. This review focuses on evolutionary aspects of
dosage compensation, in light of recent advances in
comparative and functional genomics that have
substantially increased our understanding of the
molecular mechanisms of dosage compensation and
how it evolved. We review processes involved in sex
chromosome evolution, and discuss the dynamic
interaction between Y degeneration and the acquisi-
tion of dosage compensation. We compare mecha-
nisms of dosage compensation and the origin of
dosage compensation genes between different taxa
and comment on sex chromosomes that apparently
lack compensation mechanisms. Finally, we discuss
how dosage compensation systems can also influence
the evolution of well-established sex chromosomes.
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The evolution of heteromorphic sex chromosomes
and the pressure to increase X-linked expression
in males
Species with separate sexes are widespread among
animals and plants. Sex determination can vary
widely within clades, with mechanisms as different
as environmental and genetic determination occurring
in related species, which indicates frequent de novo
evolution of sex-determining mechanisms (Bull
1983). Heteromorphic sex chromosomes—such as
the XY pair of mammals—have arisen independently
from ancestral pairs of autosomes several times and
display very similar characteristics, suggesting that
their evolution followed similar steps, outlined below.
Y-chromosomes can arise when a male-determining
gene appears on an autosome (in the case of male
heterogamety, such as the mammalian system; the
same principles apply in the case of female hetero-
gamety; Charlesworth 1996). From that moment on,
this newly formed sex chromosome (the proto-Y
chromosome) is always transmitted to males; muta-
tions that favour males are therefore predicted to
accumulate there, even if they have deleterious
effects in females. When a recombination event
occurs between the proto-Y and the proto-X chromo-
somes, however, some of these male-beneficial
mutations are relocated to the X, where they may
be selected against in females. Selection therefore
favours reduced recombination on the proto-Y
chromosome to protect linkage between the male-
determining gene and male-beneficial genes.
This reduced or absent recombination on the Y
incurs a long-term cost for males: by reshuffling loci
during meiosis, recombination creates a wide range of
allele combinations for natural selection to act upon,
thereby increasing the efficacy of natural selection
(Hill and Robertson 1966). In the absence of
recombination, all the sites on the chromosome are
completely linked, forcing selection to act on a
limited range of allele combinations. This has two
main consequences: first, whenever a beneficial
mutation is fixed in the population, all deleterious
mutations located on the Y chromosome that carries
the advantageous allele will become fixed simulta-
neously (Rice 1987). Second, purifying selection
against mildly or moderately deleterious mutations
will become less efficient on a non-recombining
chromosome, resulting in their gradual accumulation
on the Y chromosome (Charlesworth 1996). These
evolutionary theories predict that after recombination
is repressed, deleterious mutations in protein-coding
genes and regulatory regions, and repetitive DNA—
such as transposable elements—will quickly accumu-
late on the proto-Y. In species with relatively ancient
sex chromosomes, like mammals or D. melanogaster,
the Y chromosome has lost most of its original genes
and consists to a large extent of repetitive junk DNA
(Lahn et al. 2001). Genomic data from species that
have only recently acquired their sex chromosomes
have shown that the Y chromosome shows higher rates
of amino-acid substitution (probably reflecting an
accumulation of deleterious mutations) and frame-shift
mutations, an accumulation of transposable elements
and disrupted patterns of gene expression (Guttman and
Charlesworth 1998;C h a r l e s w o r t h2004; Liu et al.
2004;B a c h t r o g2006;B a c h t r o ge ta l .2008).
Different strategies of solving the dosage problem:
up- and down-regulation of X chromosomes
in mammals, worms and flies
As genes on the Y chromosome degenerate, males are
left with only one functional copy of X-Y genes,
leading to imbalances of X-linked versus autosomal
gene expression. This favours the evolution of
mechanisms that increase the expression of genes on
the single male X chromosome, i.e. dosage compen-
sation (Charlesworth 1978; Engelstädter 2008). Dos-
age compensation was first discovered in D.
melanogaster by H. Muller and has been extensively
studied in Drosophila, Caenorhabditis, and mammals
(reviewed in Straub and Becker 2007; see Fig. 1). In
Drosophila, dosage compensation is achieved by
doubling the expression of X-linked genes in males,
using a male-specific ribonucleoprotein complex.
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Fig. 1 The evolution of dosage compensation in flies, mammals
and worms. Sex chromosomes originated independently many
times from ordinary autosomes, and Y degeneration is a general
facet of sex chromosome evolution (i.e. mutational melt-down of
genes and accumulation of transposable elements and satellite
DNA). Selective pressure to restore expression levels of X-linked
genes relative to autosomes in males accompanies Y-chromosome
degeneration, thus driving the evolution of dosage compensation.
In Drosophila, dosage compensation is achieved by up-regulation
ofX-linked genes in malesonly, andnofurthermodificationofX-
linked expression is necessary. In mammals and C. elegans,t h eX
has become up-regulated in both sexes. While this ensures proper
expression balance between X-linked and autosomal genes in
males, the X will be over-transcribed in females, and secondary
mechanisms have evolved to restore proper gene dose in females.
In mammals, one X-chromosome has become completely
inactivated, while Caenorhabditis halves expression from both
of its X chromosomes in hermaphrodites
Evaluation of dosage compensation 587Under this form of dosage compensation, no second-
ary adjustments of expression levels of X-linked
genes in females are necessary (Fig. 1).
The classical view of dosage compensation in
mammals and C. elegans is that females halve the
expression of X-linked genes to equalize gene expres-
sion between the sexes. Evolutionary biologists, how-
ever, noted early on that selection acts on individuals,
so that a pressure to equalize expression differences
between the sexes cannot account for the evolution of
these compensation mechanisms. Furthermore, simple
down-regulation of the X in females would only
exacerbate the X/autosomal expression dosage differ-
ence, since dosage imbalances would then affect
females as well as males (Gupta et al. 2006). Thus,
it was suggested that there is in fact up-regulation of
expression of X-linked genes, but that unlike in
Drosophila, this up-regulation of X-linked genes was
not male-specific but occurred in both sexes. In order
to restore correct gene dose between the X and
autosomes in females, repression of X-linked expres-
sion in females would have to evolve secondarily
(Fig. 1). Charlesworth (1978; 1996)p r e s e n t e da
verbal sketch of this model, and it was recently
modelled theoretically. Assuming that males with a
single active allele have suboptimal levels of X-linked
expression and females with two active copies have
the optimal level of gene expression, Engelstädter and
Haig (2008) explored under which conditions in-
creased X-linked gene expression in both sexes
followed by X inactivation in females can evolve.
They showed that up-regulation of X-linked genes in
both sexes can evolve, as long as the fitness reduction
in females is small relative to the fitness increase in
males. Experiments in Drosophila support the notion
that the deleterious effects of gene dosage reductions
are generally more pronounced than those of similarly
sized gene dosage increases (Lindsley et al. 1972).
The theoretical prediction that inactivation or down-
regulation of the X in females has evolved in response
to up-regulation of the X in both sexes has recently
been confirmed through exhaustive comparisons of
X-linked and autosomal expression levels in mouse,
humans and C. elegans. In particular, expression from
X-linked genes in all sampled tissues is, on average,
approximately equal to that from autosomal genes
both in females and in males (Gupta et al. 2006;
Nguyen and Disteche 2006; Lin et al. 2007). The
actual mechanism behind this up-regulation of X-
linked genes in both sexes is unknown, and molecular
studies so far have focused on understanding the
pathways controlling female repression of X-linked
over-expression. It is possible that X-linked genes are
selected individually for promoters with increased
activity; however, examination of expression profiles
in mouse germ cells and early zygotes suggests that
up-regulation is absent from haploid germ cells but is
rapidly established upon fertilization, suggesting a
more elaborate, chromosome-wide regulatory mecha-
nism (Nguyen and Disteche 2006).
Molecular mechanisms of dosage compensation:
the importance of chromatin modifying complexes
While the mechanisms of dosage compensation differ
markedly between taxa, each well-studied case
involves the recruitment of a chromatin regulatory
complex to modulate the expression on the entire X
chromosome (Straub and Becker 2007). In D. mela-
nogaster, a male-specific RNA-protein complex—the
dosage compensation complex (DCC)—binds to the
male X chromosome and doubles its expression,
thereby readjusting the X to autosomal expression
ratio. The DCC requires at least five “male-specific
lethal” (MSL) proteins (msl-1, msl-2, msl-3, mle, and
mof), and two (functionally redundant) non-coding
RNAs, roX1 and roX2 (Park and Kuroda 2001). The
DCC (or MSL-complex) binds almost exclusively to
specific sites along the X chromosome, where it
interferes with chromatin folding by acetylating lysine
16 of H4, a histone required for the folding of
nucleosomal arrays into 30 nm fibres, possibly making
the genetic material more readily accessible to the
transcription machinery (Park and Kuroda 2001).
As noted above, the mechanisms resulting in non-
sex-specific up-regulation of X-linked genes in
mammals and worms are unknown, and molecular
studies have instead concentrated on understanding
the inactivation or down-regulation of X-linked
transcription in females (or hermaphrodites). Mam-
mals achieve down-regulation of X-linked genes in
females by abolishing transcription of one copy of the
X chromosome in each cell (Lyon 1961), through a
process known as X-inactivation (see Payer and Lee
2008 for a detailed review of the molecular mecha-
nisms involved). X-inactivation is controlled by one
X-linked locus only, the X-inactivation center (XIC),
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involved in mediating X chromosome inactivation,
Xist and Tsix. Xist and Tsix are antisense RNAs (they
originate from the same locus, but are transcribed in
opposite directions) and function as mutual repressors
of transcription. The Tsix copy located on the
inactive X chromosome is repressed, so that Xist is
highly transcribed and coats the X chromosome,
recruiting the proteins that cause its heterochromatic
state; on the active X, Tsix is expressed, and Xist
expression is repressed. Two Polycomb repressive
complexes, PRC1 and PRC2, are recruited to the X
chromosome that is coated with Xist and modify
histones, leading to a stably inactivated X (Straub
and Becker 2007).
C. elegans females (or more accurately, XX
hermaphrodites) have adopted a similar strategy to
mammals, but halve the transcription rate of each
X-chromosome instead of completely inactivating one
copy (Meyer and Casson 1986). This requires the
action of a dosage compensation complex formed by
at least nine proteins, several of which are also
involved in sex-determination (the sex determination
and dosage compensation genes, or SDC genes). All
the genes that form the C. elegans DCC are supplied
maternally to both XX and XO embryos, with one
exception: SDC-2 is expressed exclusively in XX
embryos, where it mediates both the development of a
hermaphroditic phenotype and the recruitment of the
DCC proteins to the DCC (Dawes et al. 1999). A
subset of these proteins then form a condensin-like
subdomain, which is thought to be responsible for the
chromatin modifications that cause the decreased
expression levels on the X (Hagstrom and Meyer
2003).
Recognition of the X chromosome: cis-elements
and spreading
One aspect of the process of dosage compensation that
remained elusive until recently is the specific targeting
of the X chromosome by the DCC. Recent studies
p o i n tt om e c h a n i s m so fd o s a g ec o m p e n s a t i o nt h a t
combine recognition and targeting of the X chromo-
some by the DCC which involves degenerate DNA
sequence motifs together with spreading of modifica-
tions in cis from recognition sites, resulting in complete
coating of the X chromosome by the DCC. However,
the relative importance of targeting versus spreading is
surprisingly different between flies, worms and mam-
mals (Fig. 2). The simplest targeting mechanism exists
in humans, where X-inactivation is controlled by a
single X-linked locus only—the X-inactivation center
(XIC)—which directs silencing to flanking chromatin
(Fig. 2). Interestingly, translocations of the XIC to an
autosome lead to at least partial inactivation of the
XIC-carrying autosome, suggesting that no further
sequence signalling along the chromosome is essential.
However, while silencing of autosomal chromatin will
occur, silencing does not spread as far or repress as
stably as when it occurs on the X chromosome (White
et al. 1998). Thus, X-linked sequence elements that
promote the spread and maintenance of silencing have
been proposed, and a candidate sequence that is
enriched on the X and facilitates spread of silencing
in X:A translocations is a class of LINE elements. It
h a sb e e ns u g g e s t e dt h a ti nh u m a n sa sm a n ya s1 5 %o f
X-linked genes consistently escape X-inactivation
(Carrel and Willard 2005); thus, regions of the X
chromosome that escape X-inactivation would need to
have acquired additional signals that repress the
spreading of the inactivation machinery. However,
escape from X inactivation in humans can, to a large
extent, be explained by the evolutionary history of the
sex chromosomes. Several “evolutionary strata” have
been identified on the mammalian sex chromosomes,
which correspond to different time points of recombi-
nation suppression between the proto-sex chromo-
somes. Almost all of the human genes in the oldest
stratum are inactivated, and most of the genes that
escape X inactivation are located in the most recent
stratum. This supports the idea that secondary Xist
regulating sites are located along the X chromosome to
modulate and stabilize Xist-binding.
Recognition of the X in Drosophila also follows a
two-step model (Kelley et al. 1999); however, unlike
in mammals, many more chromosome entry sites that
recruit the DCC to the X chromosome in a sequence-
dependent manner have been identified, and spread-
ing occurs over much smaller distances (Fig. 2).
Initial suggestions that the X chromosome of Dro-
sophila possesses only 35–40 high-affinity “entry
sites” that the DCC recognizes and binds to, followed
by spreading in cis along the entire chromosome,
were experimentally supported by translocations of
identified X chromosome entry points onto auto-
somes. This led to DCC binding not only to the
Evaluation of dosage compensation 589translocated locus, but often also to the adjacent
autosomal regions (Kageyama et al. 2001). However,
many X chromosome segments were shown to
associate normally with the DCC when translocated
onto autosomes, independently of whether they
contained a described DCC entry site (Fagegaltier
and Baker 2004). Recent experimental work using
high-resolution ChIP-seq mapping has identified
many additional chromosome entry sites, and sup-
ports a two-step model of DCC recruitment to the X
chromosome of Drosophila. The DCC complex is
thought to first target >150 (and up to 300) chromatin
entry sites containing specific DCC recognition ele-
ments on the X chromosome in males (Alekseyenko et
al. 2008; Sural et al. 2008). These entry sites appear to
consist of combinations of degenerate DNA motifs
enriched for repetitive sequences. After this initial,
sequence-specific recognition step, local spreading
from entry sites in cis along the X chromosome is
thought to lead to DCC binding to the majority of
actively transcribed genes on the X chromosome
(Alekseyenko et al. 2008). Although secondary bind-
ing signals on the X may also play a role, cis
spreading to the majority of X-linked genes occurs
primarily through the recognition of H3K36-
methylated nucleosomes (a general features of tran-
scribed genes) by MSL-3, and is therefore largely
independent of further sequence signals (Larschan et
al. 2007; Sural et al. 2008).
Targeting of the X by the C. elegans DCC follows
a similar approach to Drosophila, where DCC-
recruiting signals of different affinities occur along
the X chromosome. However, there appears to be a
lower density of these binding sites on the X of C.
elegans compared to Drosophila, implying spreading
of the DCC over larger physical distances along the X
chromosome in C. elegans (Fig. 2). Some large
sections of the C. elegans X chromosome do not
recruit the DCC when translocated to autosomes
despite being associated with the DCC and normally
Fig. 2 Recognition of the X chromosome: cis-elements and
spreading. In humans, a single primary targeting site—the
X-inactivation center (XIC)—serves as the entry site from
which spreading of silent heterochromatin along one entire X
chromosome occurs. In C. elegans, several primary recruitment
sites occur on the X chromosome (to date, about 40 such high-
affinity sites have been identified), from which spreading of the
DCC in cis occurs. Two types of DCC-binding sites have been
characterized experimentally in C. elegans: rex sites (recruitment
elements on X) and dox sites (dependent on X). rex sites—which
consist of clusters of at least two small consensus motifs—are
the primary binding sites of the DCC on the X and recruit the
DCC independent of their genomic location. The more frequent
dox sites only bind the DCC when they are located on the X, and
are thought to be responsible for the spreading of the DCC. D.
melanogaster harbours >150 high affinity sites that contain a
degenerate sequence motif and which are targeted by the DCC
in a sequence-specific manner. After this initial recognition step,
local spreading from entry sites in cis along the X leads to DCC
binding to the majority of actively transcribed genes on the X
chromosome. Although secondary binding signals on the X may
play a role in Drosophila, cis spreading occurs primarily through
the recognition of H3K36-methylated nucleosomes (a general
features of transcribed genes)
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This suggests that their association with the DCC in
their native X location results from spreading from
flanking DCC-binding sequences over significant
physical distances. Thus, a plausible model of X
recognition in C. elegans involves widely spaced cis-
acting DCC entry sites and significant spreading from
these sites to coat the entire chromosome. Consistent
with this model, two types of DCC-binding sites have
been characterized experimentally in C. elegans (Jans
et al. 2009): rex sites (recruitment elements on X) and
dox sites (dependent on X). rex sites are the primary
binding sites of the DCC on the X and consist of
clusters of at least two small consensus motifs
(McDonel et al. 2006). They recruit the DCC
independent of their genomic location. The more
frequent dox sites only bind the DCC when they are
located on the X, and are thought to be responsible for
the spreading of the DCC. They do not share the
consensus motifs of rex sites, but do show an
enrichment for a different G-rich 18bp motif (Jans et
al. 2009). Since dox sites do not have the sequence
signals required to independently recruit the DCC, it
is possible that, like in Drosophila, other properties of
the chromatin play a role in the secondary binding of
the DCC (Jans et al. 2009).
What can we learn from these three examples of
mechanisms of dosage compensation? First, as pre-
dicted since the sixties but only recently documented
experimentally, all dosage compensation mechanisms
operate to increase the expression of X-linked genes
in males (instead of equalizing expression of X-linked
genes between the sexes). If this is achieved by
up-regulating X-linked expression through the action
of a male-specific DCC, as in Drosophila, no further
modulation of expression is necessary. If the expres-
sion of X-linked genes is up-regulated in a non-
gender-specific manner, a second pathway is required
to secondarily down-regulate expression in females.
A second interesting point is that, although they
are not homologous, use different genes, and ulti-
mately work in opposite ways, the C. elegans and D.
melanogaster dosage compensation pathways share
several characteristics. In these organisms, dosage
compensation is achieved by means of sex-specific
DCCs that originated through co-opting of genes
involved in sex-determination. This is particularly
visible in C. elegans, where the two pathways overlap
repeatedly. In Drosophila, the Sxl gene, an RNA
splicing enzyme, is expressed specifically in XX
embryos, where it initiates the cascade leading to the
female phenotype. One of the targets of Sxl is the
mRNA of msl-2, a protein required for DCC
assembly. In the presence of Sxl, the msl-2 mRNA is
spliced into an inactive form, which effectively
inhibits the formation of the DCC in females (Bashaw
and Baker 1995; Kelley et al. 1995; Zhou et al. 1995).
The specific targeting of the X chromosome in these
two species is also similar, with initial binding of the
DCC to high affinity entry points on the X, followed
by spreading to adjacent regions, possibly assisted by
secondary, lower affinity binding sites. This contrasts
sharply with mammalian dosage compensation, which
has neither a sex-specific DCC nor chromosome-
specific targeting; instead, all chromosomes carrying
the XIC locus are targeted, and it is the number of
X-chromosomesinthecellthatinitiatesXist expression,
not the sex in which they are located. These differences
between mammals and C.elegans/D.melanogaster may
reflect differences in the evolutionary history of their
DCC; we discuss this possibility below.
The role of non-coding RNAs should also be
emphasized, as they play a key role in the targeting of
the X in both mammals and Drosophila. This is in line
with recent literature highlighting the importance of
non-coding RNAs for the regulation of gene expres-
sion (Mattick et al. 2009), although most of the known
examples concern gene silencing, whereas in Drosoph-
ila the roX genes are used for upregulation. Finally,
once the mechanisms that control X chromosome up-
regulation in mammals and nematodes are character-
ized, it is well possible that further characteristics
common to all three organisms will be identified.
The evolutionary origin of dosage compensation
genes: recruitment of pre-existing regulatory
complexes
As discussed above, dosage compensation differs
greatly between the various organisms under study,
and involves different genes. With the availability of
whole genome sequences of several fly, nematode and
mammalian species, another important question can
be addressed: how are protein complexes created and
recruited to perform newly evolved functions, such as
dosage compensation in response to Y degeneration?
While the mechanics of dosage compensation differs
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studied case it involves the recruitment of a pre-
existing chromatin regulatory system to modulate
expression of an entire X chromosome. The proteins
that participate in these chromatin-modifying com-
plexes appear to have an ancestral association that
predates their role in dosage compensation. Thus, the
evolution of dosage compensation does not require
the emergence of novel regulatory proteins but
instead the evolution of a recruiting mechanism that
targets pre-existing regulatory complexes to a specific
chromosome.
Several proteins of the Drosophila DCC have
conserved homologs in nematodes, mammals and even
in yeast (Hilfiker et al. 1997; Eisen et al. 2000). A
complex that contains all msl protein homologs but one
(mle, which may have gone undetected since it appears
to have a more peripheral association with the complex
in flies) has been detected in mammals (Smith et al.
2005). The human MSL-complex homolog is also
involved in acetylating histone H4 at lysine 16, but
binds to all chromosomes, and in both sexes, suggest-
ing that a housekeeping complex present ancestrally
was co-opted for dosage compensation in Drosophila.
MOF, the DCC protein directly responsible for the
acetylation of histone H4, has recently been found to
perform the same function on the promoter region of
genes located on the X and autosomes of both sexes in
Drosophila (Kind et al. 2008). It therefore appears
possible for an epigenetic pathway to be recruited for
dosage compensation while maintaining its original
regulatory function. The recruitment of this epigenetic
complex for male-specific up-regulation of X-linked
genes in Drosophila is likely to have occurred
relatively rapidly, as DCC-protein homologs are not
involved in dosage compensation of another Dipteran
insect, Sciara ocellaris (Ruiz et al. 2000), although the
MSL complex has been shown to mediate dosage
compensation in several other Drosophila species. An
interesting recent discovery regarding chromosome-
wide regulation in fruit flies involves an autosome-
specific protein, POF (Painting of Fourth). POF is a
putative RNA binding protein that specifically binds
the tiny fourth chromosome of both sexes in D.
melanogaster (Larsson and Meller 2006). Surprisingly,
in D. busckii—a species in which the fourth chromo-
some has become fused to the ancestral X chromo-
somes—POF paints the entire X chromosome in males
only, suggesting that POF is participating in dosage
compensation, while no MSL binding to the male X
was detected (Larsson et al. 2000). This suggests that
an alternative system of dosage compensation may be
used even within the genus Drosophila.H a d d r i l le ta l .
(2007) found that genes located on the D. mela-
nogaster fourth chromosome have, on average, higher
levels of expression than genes on other chromosomes,
which they interpret as a response to reduced gene
activity caused by the accumulation of deleterious
mutations on this non-recombining chromosome.
However, increased expression of genes on chromo-
some four could also result from their association with
POF, if POF-related mechanisms were ancestrally
responsible for achieving dosage compensation in
Drosophila.
Unlike the msl proteins, roX1 and roX2 are not
present in the human MSL-complex. The non-coding
RNAs have been shown to be essential for specific
DCC binding to the X chromosome (Li et al. 2008),
indicating that the recruitment of the roX genes to the
MSL-complex may have been a crucial step in the ac-
quisition of dosage compensation in Drosophila. The
origin of roX1 and roX2,h o w e v e r ,r e m a i n sam y s t e r y ,
as no homologs have been found in the genome of the
Dipteran insect Anopheles gambiae (Inagaki et al.
2005). Even within the genus Drosophila, not all
species appear to have both roX genes (Park et al.
2007). Since roX1 and roX2 are functionally redundant
in D. melanogaster, this may not be surprising, and
identifying non-coding genes based on sequence
conservation poses a general difficulty. However,
despite low homology between roX genes identified
in various Drosophila species, male-specific expression
and X chromosome-specific binding of roX genes are
conserved (Park et al. 2007).
A similar recruitment of ancestral epigenetic
mechanisms that regulate chromatin compaction to
perform dosage compensation functions occurred in
C. elegans. In this species, three proteins of the DCC
(DPY-26, DPY-27 and DPY-28) show similarity to
proteins of the 13S condensin (Chuang et al. 1994;
Lieb et al. 1996; Hagstrom and Meyer 2003), a
mitotic complex involved in chromatin compaction and
nucleosome resolution that is conserved from prokar-
yotes to eukaryotes (Hirano 1999). Another protein of
the DCC, MIX-1, is a member of both the DCC and
the 13S condensin complex (Lieb et al. 1998;
Hagstrom et al. 2002). In addition to being similar to
a condensin protein, DPY-28 participates in crossing
592 B. Vicoso, D. Bachtrogover regulation in the germline, further highlighting the
dual function of some DCC proteins (Tsai et al. 2008).
Additional DCC subunits confer sex specificity to the
dosage compensation process and recruit the
condensin-like DCC subunits to X chromosomes.
Understanding the origin of Xist and Tsix proved
challenging, as these non-coding RNAs are found
only in eutherian mammals (Duret et al. 2006), where
they are conserved (Chureau et al. 2002). Recently, a
region homologous to the mammalian XIC region has
been identified in the chicken genome (Duret et al.
2006). Although the genes flanking the XIC were
found to be syntenic in these species, no RNA gene
was found to correspond to Xist; instead, a protein
coding gene of unknown function, Lnx3, was identi-
fied in the expected Xist region. Further analysis
showed that, although Xist is much larger than Lnx3
and contains no protein coding sequence, some of its
exons present significant similarity to Lnx3, indicating
that Xist originated from Lnx3 (Duret et al. 2006).
This has occurred at least partly through the acquisi-
tion of additional transposable-element-derived exons
(Elisaphenko et al. 2008). Similarly, other XIC genes
appear to have evolved by pseudogenization of coding
genes of the ancestral XIC region (Elisaphenko
et al. 2008).
Several lines of evidence suggest that transpos-
able elements (TEs) played an important role in
the acquisition of dosage compensation. As men-
tioned above, several XIC genes evolved by
accumulating TE repeats in their coding sequence.
Lyon (1998) also postulated that LINE elements may
play a role in the spreading and stabilizing of the Xist
RNA on the X chromosome, a theory supported by
the higher frequency of LINE elements on the human
X than on the autosomes, particularly around the
XIC (although this accumulation of LINE elements
is not detected in the mouse XIC region). A direct
demonstration that dosage compensation and trans-
posable elements are closely related in Drosophila
was provided by Matyunina et al. (2008), who
showed that MOF, one of the DCC proteins of
Drosophila, is also involved in the repression of the
copia LTR retrotransposon. This close relation
between transposable elements and dosage compen-
sation may reflect the history of epigenetic mecha-
nisms, which are thought to have originated
primarily as a defence against transposable elements
(Matyunina et al. 2008).
The evolution of dosage compensation: dynamic
interactions between Y degeneration and dosage
compensation
Although the mechanisms underlying dosage com-
pensation are well studied, understanding how they
arise, and the steps by which they arise, will require
further investigations. A longstanding question in the
study of how dosage compensation evolved has been
whether the regulation of X-linked gene expression
occurs independently for each gene, or whether large
blocks of the X chromosome become dosage-
compensated simultaneously (Fig. 3). Resolving this
question has several important implications. The first
concerns the different models of Y-chromosome de-
generation, as they may predict different steps in the
evolution of dosage compensation, depending on their
underlying evolutionary parameters (Charlesworth
1996). If the Y chromosome degenerates primarily
through “hitchhiking” of strongly deleterious muta-
tions when beneficial variants are swept to fixation,
each of these sweeps will only carry a relatively small
number of deleterious mutations at few genes to
fixation. If such selective sweeps fixing strongly
deleterious mutations only occur sporadically, then
this model of Y-degeneration may predict that dosage
compensation should evolve on a gene-by-gene basis
(Fig. 3). If the Y degenerates mostly as a result of
inefficient removal of mildly deleterious mutations
from the population—or if recurrent selective sweeps
are common and fix a large number of mildly
deleterious alleles simultaneously—all genes on a
proto-Y will decay at similar rates, but individual
genes will only be impaired very slightly. Under this
scenario, selection may not be strong enough to
acquire dosage compensation at individual genes,
but instead the entire X will be under selective
pressure to increase gene expression, leading to large
blocks of the X being compensated at once (Fig. 3).
The relative importance of a few, strongly deleterious
mutations versus many weakly deleterious mutations
in causing Y degeneration is not known, and depends
on many poorly known population parameters, such
as the mutation rate for both beneficial and deleteri-
ous alleles, and their underlying distributions of
selective effects.
In addition, the temporal dynamics of Y degener-
ation is expected to change over time, due to—among
other factors—changes in the number of functional
Evaluation of dosage compensation 593genes on a degenerating Y chromosome. It has been
shown that this reduction in functional genes can
result in different processes of Y degeneration
dominating different evolutionary stages in the tran-
sition of a gene-rich proto-Y chromosome into a
degenerate Y (Bachtrog 2008a). In particular, purify-
ing selection to remove mildly deleterious mutations
from the population may be particularly ineffective on
a young, gene-rich Y chromosome, while selective
sweeps driving the fixation of more strongly delete-
rious mutations may become more important at later
stages of Y degeneration (Bachtrog 2008a). This
could favour a block-model of dosage-compensation
in the early stages of sex chromosome evolution, and
select for genes becoming compensated individually
later on. Again, however, the exact temporal dynam-
ics of Y degeneration depends on many poorly known
evolutionary parameters, making quantitative predic-
tions on how we would expect dosage compensation
to evolve difficult.
Although both types of interference effects are
likely to participate in the degeneration of the
Y chromosome after recombination is repressed,
Charlesworth (1996) pointed out that different pop-
ulations might be affected to different extents by the
two effects depending on their effective population
X
Y
X
Y
X
Y
X
Y
Accumulation of strongly 
deleterious mutations at few loci
Accumulation of mildly deleterious 
mutations at many loci 
Block-by-block DC  Gene-by-gene DC
Selection for Y inactivation?
proto-X
proto-Y
X
Y
LEGEND
Gene
mRNA
strongly deleterious
mildly deleterious
Fig. 3 Gene-by-gene or block-by-block acquisition of dosage
compensation. As proto-Y-chromosomes accumulate deleteri-
ous mutations, genes become randomly mal-adapted or inacti-
vated on the proto-Y. Dosage compensation can either evolve
on a gene-by-gene basis, i.e. whenever a gene becomes inactive
its homolog on the X becomes dosage compensated. Alterna-
tively, once a certain number of genes become mal-adapted or
inactive on the proto-Y, blocks of genes on the X become
dosage compensated simultaneously. Different models of Y
degeneration may drive the evolution of different modes of
dosage compensation. In particular, Y-degeneration driven by
the accumulation of strongly deleterious mutations at few loci
may favour dosage-compensation mechanisms to evolve on a
gene-by-gene basis, while the accumulation of many weakly
deleterious mutations may select for dosage compensation at
the level of blocks of genes. If blocks of genes become dosage
compensated simultaneously on the X chromosome, this could
in turn result in selective pressure to down-regulate mal-
adapted or even fully functional genes on the Y, in order to
restore proper expression balance for these genes in females
594 B. Vicoso, D. Bachtrogsize. Species with smaller effective population sizes,
such as mammals, are likely to be strongly affected by
the accumulation of moderately deleterious mutations
that are not being efficiently removed from the
population. Flies and nematodes, on the other hand,
have much larger effective population sizes (the current
effective population size of C. elegans is quite small,
but evidence suggests that this is due to a recent
reduction in effective population size from a large
ancestral population; Cutter 2006)a n dm a yt h e r e f o r e
have evolved to a greater extent through the hitchhik-
ing of more strongly deleterious mutations together
with beneficial alleles. As pointed out above, mamma-
lian dosage compensation does indeed have character-
istics that set it apart; interestingly, X-inactivation
seems to be primarily a chromosome-wide mechanism,
with a few genes escaping X-inactivation. Dosage
compensation in C. elegans and D. melanogaster
appears to be much more localized, with a multitude
of binding sites located along the X. This is in
agreement with this theory of many weakly deleterious
mutations accumulating on the proto-Y chromosome in
mammals at many genes, selecting for large blocks on
the X to be compensated simultaneously, while more
strongly deleterious mutations fixing by hitchhiking
with beneficial alleles in C. elegans and Drosophila
select for more localized mechanisms of dosage
compensation.
It should be noted, however, that it is of course
possible that the repression of X-linked expression in
mammalianfemalesinitiallyevolvedonagene-by-gene
basis, and that a chromosome-wide mechanism of
X-inactivation was secondarily adopted. Furthermore,
nothing is known about the molecular basis for the
initial up-regulation of X expression in mammals
affecting both sexes, which may also be regulated
independently for each gene. However, it appears
sensible for the two mechanisms (up-regulation of the
X in both sexes, and inactivation of the X in females) to
evolve in parallel, and chromosome-wide mechanisms
for up-regulation of X genes in mammals are supported
by experimental data (Nguyen and Disteche 2006).
In general, mechanisms of dosage compensation
that have been well-established for millions of years
only provide limited information on how they were
created in the first place. An approach that has proved
useful in understanding the early steps of sex
chromosome evolution consists in studying sex
chromosomes that have only recently evolved. These
can fall into two categories: true newly evolved sex-
chromosomes, and autosomes that have become fused
to sex-chromosomes (neo-sex chromosomes). Several
neo-X chromosomes in the genus Drosophila have
evolved dosage compensation over some or all of
their length, by co-opting the existing dosage com-
pensation machinery. For example, D. miranda has a
neo-sex chromosome system that was formed only
about 1 million years ago, and roughly half of the
genes originally present on the neo-Y are already
degenerate (Bachtrog et al. 2008). This massive
degeneration of gene function on the neo-Y (involv-
ing over 1000 genes) has triggered an evolutionary
response in its former homolog, the neo-X, which is
already partly recruiting the molecular machinery
necessary for dosage compensation. Targeting of the
DCC to the neo-X chromosome of D. miranda must
have involved the recent (adaptive) fixation of many
de novo binding sites for the dosage compensation
machinery. Interestingly, rates of adaptive evolution
on the neo-X chromosome of D. miranda were shown
to be about 10-fold higher than background levels of
adaptation in the genome (Bachtrog et al. 2009),
consistent with the action of positive selection at
many genomic regions to acquire binding sites for the
DCC on the neo-X.
The mode of how dosage compensation evolved in
response to mutation accumulation on the Y can
potentially affect the process of Y degeneration itself
(Fig. 3). In particular, if dosage compensation evolves
in a block-by-block manner, large segments of a proto-
Y chromosome may become functionally redundant.
Both genes which have only very slightly impaired
functions and genes that are fully functional on the Y
chromosome could become dosage compensated on
the X and may therefore decay neutrally on the Y.
Thus, under a block-model of dosage compensation,
the rate of Y degeneration will be greatly increased
once a genomic region acquires dosage compensation.
In fact, under this scenario it may actually become
beneficial to down-regulate either mal-adapted or fully
functional genes on a proto-Y chromosome which are
dosage compensated on the X, to restore proper gene
dose for these genes in males. Genes could become
down-regulated individually by mutations in their
regulatory sequences or by transposable element
insertions, or large regions of evolving Y chromo-
somes could become transcriptional silenced simulta-
neously by epigenetic modifications, such as
Evaluation of dosage compensation 595heterochromatinization. Thus, under a block-by-block
model of dosage compensation, Y degeneration, at
some time point, will become an adaptive process.
Interestingly, the neo-Y chromosome of D. miranda
has been shown to have undergone recent positive
selection (Bachtrog 2004). While it is of course
possible that some genes evolved male-beneficial
functions, this could also reflect adaptive down-
regulation of neo-Y genes that are dosage compensated
on the neo-X. Further studies of sex chromosomes
that are in the process of acquiring dosage compensa-
tion will help uncover the dynamic interactions
between Y degeneration and the evolution of dosage
compensation.
The glitch in the theory: lack of dosage
compensation in ZW systems
We have focused so far on the most frequent sex-
chromosome system, male heterogamety. Female
heterogamety (males are ZZ, females are ZW), the
system found in birds, moths and butterflies, provides
an interesting complement to the previous studies, as
it allows us to examine separately the consequences
of always being transmitted through males (which
often have, for instance, a higher mutation rate) from
other predictions of sex chromosome evolution theory
that are expected to affect both systems equally. In
agreement with theories of sex chromosome evolution
(see above), W chromosomes are very similar to Y
chromosomes: they contain few functional genes and
are mostly heterochromatic, have low sequence
diversity and high rates of non-synonymous diver-
gence compared with the autosomes (Berlin and
Ellegren 2005; Berlin et al. 2007; Vitkova et al.
2007). Since most genes on Z-chromosomes lack a
homolog on the W, these same theories therefore
predict that Z-linked genes should also be dosage-
compensated in females.
An early examination of chromatin condensation
showed no difference between Z chromosomes and
autosomes in birds (Cock 1964), which suggested
absence of dosage compensation (in male heteroga-
metic systems, dosage compensation is detectable by
differences in chromatin compaction of dosage-
compensated X chromosomes). Small-scale studies
of gene expression at few loci in birds and butterflies
reached similar conclusions (Johnson and Turner
1979; Baverstock et al. 1982), leading to the puzzling
suggestion that ZW systems may not have evolved
dosage compensation.
More recently, female and male expression levels
were systematically compared in birds using micro-
array studies (chicken and zebrafinch) and a few
Z-linked genes were in fact shown to be dosage
compensated. However, the main conclusion of these
genome-wide studies remained that in birds dosage
compensation seems to be the exception rather than
the rule, and most Z-linked genes are expressed at
significantly higher levels in males than females
(Ellegren and Parsch 2007; Arnold et al. 2008). A
recent expression analysis of over 500 genes located
on the Bombyx mori (silkworm) Z chromosome
detected a similar pattern in this species, with a vast
majority of Z-linked genes presenting male-biased
expression levels (Zha et al. 2008).
Several explanations have been put forward to
account for this puzzling observation. Since not all
genes function in a dosage dependent manner, some
organisms with heteromorphic sex chromosomes will
simply not require the development of chromosome-
wide mechanisms of dosage compensation, indepen-
dently of which sex is heterogametic (Graves and
Disteche 2007). In particular, the necessity of evolv-
ing dosage compensation may depend on both the
types of genes initially present on the sex chromo-
somes, and the number of genes located on the
degenerating Y. Experimental data suggest that hemi-
zygosity at a few genes or small genomic regions is
usually tolerated, while hemizygosity over extended
segments or entire chromosomes is lethal. If Z
chromosomes of birds and Lepidoptera are generally
gene-poor, a lack of dosage compensation in these
species could simply result from sufficient buffering
of the genome against small regions of hemizygosity,
accompanied by individual up-regulation of the few
genes that are dosage-sensitive. X chromosomes of
Drosophila, C. elegans and humans are gene-rich,
harbouring roughly 2300, 3100, and 1500 genes,
respectively. The Z chromosomes of both Bombyx
and chicken contain slightly fewer genes, with
roughly 840 and 600 protein-coding genes identified
on the chicken and the silkworm Z chromosome,
respectively. However, hemizygosity of several hun-
dred genes is usually lethal in Drosophila, suggesting
that the lack of dosage compensation in chicken and
Bombyx does not simply result from a low gene
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pairs are still in the early stages of dosage compen-
sation evolution, after up-regulation of the Z in both
sexes but before the increase in expression of X- or
Z-linked genes becomes sex-specific (see above).
Data obtained for birds, however, do not support this
idea: first, the Z and W chromosomes of birds
diverged approximately at the same time as the
mammalian X and Y (over a hundred million years
ago), and before the Drosophila sex chromosomes.
Second, the Z/Autosomal ratio of expression in
chicken and zebrafinch males is approximately 1
(Ellegren et al. 2007; Itoh et al. 2007), which is not
consistent with an chromosome-wide increase of
expression on the Z.
Other theories, including sexual antagonism, male-
biased mutation rates and increased egg size in ZW
species, view the lack of dosage compensation as a
consequence of female heterogamety. (a) Sexual
antagonism: It has been shown theoretically and
empirically that sexual selection, as well as sex-
specific selective forces, can lead to different accu-
mulation of genes with sex-specific functions on the
sex chromosomes (Rice 1984). Thus, it is possible
that Z-linked genes are expressed at higher rates in
males than in females not because dosage compensa-
tion is inefficient, but because these are genes with
male functions. Sexual selection theory suggests that
male secondary characters would more likely be
established in species with male homogamety (i.e.
ZZ males) than those with male heterogamety (i.e.
XY males; Reeve and Pfennig 2003; Albert and Otto
2005), and comparative analysis among a list of taxa
suggests that male secondary characters are more
e x a g g e r a t e di nZ Z / Z Ws y s t e m st h a ni nX X / X Y
systems (Reeve and Pfennig 2003). In addition, avian
Z-linked genes show evidence of accelerated rates of
functional evolution, while no such effect was found
for X-linked genes in mammals (Ellegren 2009).
Thus, the higher levels of sex-linked gene expression
in males may favour Z-linkage of genes under sexual
selection, and this effect may be more pronounced in
ZZ/ZW genetic systems than XX/XY systems. (b)
Male-biased mutation: In many organisms, the pro-
duction of female and male gametes requires different
numbers of cell divisions. Since most mutations occur
during cell division, this can lead to differences in
male and female mutation rates. A male-biased
mutation rate has been observed in mammals and
birds, and is associated with increased mutation rates
on the Y, while female-limited W chromosomes have
lower rates of mutation than other chromosomes
(Miyata et al. 1987). This effect could slow down the
degeneration of the W chromosome, allowing for sex-
specific dosage regulation to evolve on a gene by gene
basis. Although the role of mutation rates on the
degeneration of Y chromosomes has been quantified
(Engelstädter2008), the extent to which this affects ZW
systems remains to be determined. This argument is
further complicated by the fact that in many species
(including birds and mammals), recombination between
the proto-sex chromosomes is not restricted simulta-
neously over their entire length, but instead different
genomicregionsalongtheevolvingsexchromosomes—
containingonlyasubsetofthegenes—stoprecombining
at different evolutionary time points. Reducing the
number of genes within the non-recombining segments
of the proto-sex chromosomes has the same effect as
reducing the chromosome-wide mutation rate on an
evolving Y (or W) chromosome, thereby also reducing
thespeedofYdegeneration(Bachtrog2008a). Thus, the
effect of reduced mutation rates in ZW systems is
confounded by the number of genes present in each
non-recombining strata of an evolving sex chromosome
pair, of which we only have limited knowledge. (c)
Megalecithal eggs: Female-heterogametic species tend
to have large eggs (e.g. birds) that contain large
amounts of maternal mRNAs. Chandra (1991)p o i n t e d
out that this could counteract the loss of W-linked genes
that are required for early development, because
females can produce and store large quantities of these
mRNAs in the egg and transmit them to embryos. In
species with smaller eggs, such as Drosophila, maternal
RNAs are also crucial for zygotic and immediate post-
zygotic development but are soon replaced by locally
produced mRNAs; the abundance of maternal mRNAs
of ZW organisms may be sufficient for embryonic
transcription to be put on hold until morphogenesis has
been determined, thereby avoiding dosage problems at
this crucial stage (Chandra 1991). This theory assumes
that gene dose is more crucial at early stages of
development, an assumption that has not been explicitly
tested.
The extent to which each of these hypotheses
affects the evolution of Z chromosomes remains to be
determined. Furthermore, since male and female
expression levels of Z-linked genes have only been
analysed globally in two independently evolved ZW
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sation in birds and butterflies is a coincidence or if it
reflects true differences in the evolution and physiol-
ogy of ZW organisms. Further studies of female
heterogametic taxa—asfound inmanyreptile species—
will help clarify this issue. Additionally, little is
known about dosage compensation in plants that have
heteromorphic sex chromosomes. Plants may gener-
ally be more tolerant to gene dose imbalances (for
example, they are often polyploid and many genes
occur in gene families), suggesting that they could
also lack dosage compensation mechanisms. Future
studies on levels of gene expression in plants with
heteromorphic sex chromosomes will be of great
interest to determine the extent of dosage compensa-
tion in these systems.
Dosage compensation and the evolution
of well-established sex chromosomes
Most of the work reviewed here concerns the early
evolution of sex chromosomes and the acquisition of
dosage compensation mechanisms to counter-balance
gene dose deficiencies caused by the degeneration of
the Y chromosome. It is, however, worth noting that
dosage compensation can also affect the current
evolution of established sex chromosomes, both at
sequence divergence and gene movement levels, and
this may provide an explanation for some of the
peculiar patterns of evolution observed on X chro-
mosomes (Vicoso and Charlesworth 2006).
The presence of multiple DCC-binding sites along
the X chromosomes of Drosophila and Caenorhabdi-
tis is likely to constrain the evolution of non-coding
sequence. If binding sites are conserved within these
clades, the accumulation of mutations that disrupt
them will be prevented, so that non-coding sites are
expected to evolve more slowly on the X chromo-
some than on autosomes. The extent of this bias
clearly depends on the total number and size of
dosage compensation binding sites along the X, and
how easily DCC-binding sites can be lost and gained
in the genome (cis binding sites often show surpris-
ingly fast rates of turn-over between species). An
unexpected finding that emerged from D. mela-
nogaster polymorphism studies is that there is
widespread species-specific positive selection on msl
genes in this taxa (Rodriguez et al. 2007). The DNA-
binding region of the MSL complex, in particular, has
accumulated several adaptive changes, and it has been
suggested that this may be coupled with adaptive
changes at the DCC-binding sites of the X chromo-
some (Rodriguez et al. 2007). Indeed, a population
genetics study of three well-characterized binding
sites on the X chromosome has detected positive
selection at these regions in D. melanogaster, consis-
tent with the idea of adaptive co-evolution between
the DCC proteins and their binding sites (Bachtrog
2008c). The selective pressure underlying this co-
evolution is unknown, but could involve some
conflict scenarios such as male-killing bacteria that
specifically detect components of the MSL complex
or defence against transposable elements. It will be of
great interest to investigate patterns of polymorphism
at many more recently identified DCC binding sites
on the X of D. melanogaster, to confirm the finding
of adaptive co-evolution between DCC proteins and
their binding sites. Furthermore, gene expression
studies in hybrids may reveal whether X-linked genes
are more likely to be miss-expressed relative to
autosomal genes, due to incompatibilities between
DCC proteins and their binding sites. Problems in
dosage compensation in species hybrids could help to
explain the empirical observation that in species
hybrids the heterogametic sex is more likely to suffer
from sterility or inviability (known as Haldane’s rule).
A further confounding effect derives from the fact
that X-chromosomes in several species of Drosophila
tend to be more diverged at all sites, synonymous,
non-synonymous and all classes of non-coding
(Begun et al. 2007). It is possible that all X-linked
sites are under stronger positive selection and/or
weaker negative selection than the autosomes. It
seems however more likely that the mutation rate on
the X chromosome is higher than on the autosomes.
As discussed before, mutation rate differences on sex
chromosomes versus autosomes could reflect differ-
ences in mutation rates of males versus females (i.e. a
lower mutation rate in the male germline than in the
female germline could result in a higher mutation rate
of the X). However, estimates of the number of cell
divisions are similar for the male and female germ-
lines of D. melanogaster (Drost and Lee 1998; but
note that this estimates strongly dependent on the
mean mating age of males and females which are hard
to estimate in the wild). In fact, mutation rates were
estimated to be higher in males of a different
598 B. Vicoso, D. BachtrogDrosophila species, D. miranda (Bachtrog 2008b).
Another explanation that has been put forward is that
the hypertranscription of the X chromosome required
for dosage compensation may itself be mutagenic
(Begun et al. 2007). Although the relation between
transcription and mutagenesis is not completely
understood, several experimental studies have shown
that increased transcription can lead to increased
mutation rates in prokaryotes, yeast and, more
recently, mammalian cells (Hendriks et al. 2008).
Increased transcription rates associated with dosage
compensation are therefore plausible to be influencing
the mutation rate of the X chromosome. It is, however,
unclear if this can account for the increased divergence
detected at X-linked sites in Drosophila, since in this
group expression levels are negatively correlated with
divergence levels, possibly because highly expressed
genes are under stronger purifying selection against the
accumulation of non-synonymous and synonymous
mutations (Lemos et al. 2005).
Also, X chromosomes in Drosophila show a
deficiency of genes with male-biased expression,
and the mechanism of dosage compensation (i.e.
hyper-transcription of the X through epigenetic
modifications) could contribute to this observed
deficiency. In particular, the modified chromatin
structure of the X may directly interfere with
subsequent transcriptional modification of X-linked
genes in males. Male-biased gene expression origi-
nates mainly by increasing transcription of non-biased
genes in males (rather than down-regulation in
females), and higher expression levels may be harder
to achieve on an already hyper-transcribed X chro-
mosome (Vicoso and Charlesworth 2006; Vicoso and
Charlesworth 2009). The X chromosome in male
Drosophila is encumbered by the DCC and its
chromatin structure has been modified globally. This
may limit subsequent transcription factor binding or
chromatin remodelling, and thus inhibit further
transcriptional activation, resulting in a deficiency of
male-biased expression on the X chromosome. In
fact, direct interference between chromatin remodel-
ling complexes and the dosage compensation machin-
ery has been reported in Drosophila. Limitations in
rates of transcription have also been put forward as an
explanation for the deficiency of male-biased genes
on the Drosophila X (Vicoso and Charlesworth 2009).
This is supported by the observation that the
proportion of male-biased genes located on the X
differs significantly between high and low expression
genes, with high expression male-biased genes being
located less often on the X than low expression male-
biased genes. This is expected if limits in rates of
transcription prevent the accumulation of male-biased
genes on the X, since such limitations are less likely
to affect genes that are transcribed at low levels
(Vicoso and Charlesworth 2009). It will be of interest
to experimentally test whether dosage compensation
can indeed help to explain the deficiency of male-
biased genes on the Drosophila X.
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